Hydroxyurea therapy for children with sickle cell disease: describing how caregivers make this decision

BACKGROUND: Hydroxyurea (HU) is underutilized in children with sickle cell disease (SCD) because caregivers frequently decline HU when it is offered. This study explores what impacts this decision. RESULTS: Caregivers of children with clinically severe SCD whose children were offered HU previously w...

Descripción completa

Detalles Bibliográficos
Autores principales: Creary, Susan, Zickmund, Susan, Ross, Diana, Krishnamurti, Lakshmanan, Bogen, Debra L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548690/
https://www.ncbi.nlm.nih.gov/pubmed/26303306
http://dx.doi.org/10.1186/s13104-015-1344-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548690/
https://www.ncbi.nlm.nih.gov/pubmed/26303306
http://dx.doi.org/10.1186/s13104-015-1344-0

Ejemplares similares